An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping.
Shun HamadaMasashi NagaseTomohiko YoshizawaAkari HagiwaraYoshikazu IsomuraAyako M WatabeToshihisa OhtsukaPublished in: Communications biology (2021)
Optogenetic tools such as channelrhodopsin-2 (ChR2) enable the manipulation and mapping of neural circuits. However, ChR2 variants selectively transported down a neuron's long-range axonal projections for precise presynaptic activation remain lacking. As a result, ChR2 activation is often contaminated by the spurious activation of en passant fibers that compromise the accurate interpretation of functional effects. Here, we explored the engineering of a ChR2 variant specifically localized to presynaptic axon terminals. The metabotropic glutamate receptor 2 (mGluR2) C-terminal domain fused with a proteolytic motif and axon-targeting signal (mGluR2-PA tag) localized ChR2-YFP at axon terminals without disturbing normal transmission. mGluR2-PA-tagged ChR2 evoked transmitter release in distal projection areas enabling lower levels of photostimulation. Circuit connectivity mapping in vivo with the Spike Collision Test revealed that mGluR2-PA-tagged ChR2 is useful for identifying axonal projection with significant reduction in the polysynaptic excess noise. These results suggest that the mGluR2-PA tag helps actuate trafficking to the axon terminal, thereby providing abundant possibilities for optogenetic experiments.
Keyphrases
- optic nerve
- high resolution
- spinal cord injury
- heavy metals
- high density
- gene expression
- magnetic resonance imaging
- air pollution
- drinking water
- risk assessment
- drug delivery
- minimally invasive
- multiple sclerosis
- optical coherence tomography
- cancer therapy
- dna methylation
- white matter
- resting state
- magnetic resonance